A detailed history of Wharton Business Group, LLC transactions in Danaher Corp stock. As of the latest transaction made, Wharton Business Group, LLC holds 2,120 shares of DHR stock, worth $499,980. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,120
Previous 2,163 1.99%
Holding current value
$499,980
Previous $540,000 9.07%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$239.25 - $280.76 $10,287 - $12,072
-43 Reduced 1.99%
2,120 $589,000
Q2 2024

Aug 12, 2024

BUY
$235.51 - $267.98 $10,126 - $11,523
43 Added 2.03%
2,163 $540,000
Q1 2022

May 18, 2022

SELL
$257.27 - $315.76 $24,440 - $29,997
-95 Reduced 4.29%
2,120 $622,000
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $646,957 - $728,757
2,215 New
2,215 $729,000
Q3 2021

Nov 09, 2021

SELL
$272.21 - $332.43 $692,774 - $846,034
-2,545 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$225.08 - $271.69 $572,828 - $691,451
2,545 New
2,545 $683,000
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $497,250 - $574,376
-2,340 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$177.16 - $215.33 $138,539 - $168,388
-782 Reduced 25.05%
2,340 $504,000
Q2 2020

Aug 11, 2020

SELL
$128.7 - $176.83 $2,445 - $3,359
-19 Reduced 0.6%
3,122 $552,000
Q1 2020

Apr 27, 2020

BUY
$121.39 - $169.05 $2,306 - $3,211
19 Added 0.61%
3,141 $435,000
Q4 2019

Feb 04, 2020

BUY
$133.47 - $153.48 $312,319 - $359,143
2,340 Added 299.23%
3,122 $479,000
Q3 2019

Oct 30, 2019

SELL
$135.4 - $146.47 $316,836 - $342,739
-2,340 Reduced 74.95%
782 $451,000
Q3 2017

Nov 02, 2017

BUY
$79.29 - $88.45 $247,543 - $276,140
3,122
3,122 $268,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Wharton Business Group, LLC Portfolio

Follow Wharton Business Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wharton Business Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wharton Business Group, LLC with notifications on news.